Robert Wolff
Impact in
- Health Informatics top 0.5%
- Artificial Intelligence in Healthcare and Education
- Pharmacology top 0.2%
- Cannabis and Cannabinoid Research
Papers in
-
- Brain Metastases and Treatment 9
- Lung Cancer Treatments and Mutations 5
- Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Co-authors
- Jos Kleijnen (40 shared papers)Penny Whiting (8 shared papers)Karel G.M. Moons (4 shared papers)Richard D Riley (2 shared papers)Johannes B. Reitsma (2 shared papers)Gary S. Collins (3 shared papers)Kate Misso (5 shared papers)Steven Duffy (9 shared papers)
- Journals
- Cochrane Database of Systematic Reviews (15 papers)PharmacoEconomics (10 papers)PLoS ONE (4 papers)Acta Neurochirurgica (4 papers)Journal of neurosurgery (4 papers)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Robert Wolff
93 papers receiving 6.7k citations
Robert Wolff's Hit Papers
Peers
Comparison fields: 5 of 171
- Health Informatics 180
- Pharmacology 1.4k
- Hepatology 333
- Toxicology 128
- Statistics, Probability and Uncertainty 167
Countries citing papers authored by Robert Wolff
This map shows the geographic impact of Robert Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wolff more than expected).
Fields of papers citing papers by Robert Wolff
This network shows the impact of papers produced by Robert Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wolff. The network helps show where Robert Wolff may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies Hit paper breakdown → | 2018 | 1610 |
| 2 | Cannabinoids for Medical Use Hit paper breakdown → | 2015 | 1522 |
| 3 | PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration Hit paper breakdown → | 2018 | 995 |
| 4 | Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients Hit paper breakdown → | 2015 | 616 |
| 5 | 2004 | 292 | |
| 6 | 2002 | 142 | |
| 7 | 2020 | 105 | |
| 8 | 2009 | 75 | |
| 9 | 2017 | 69 | |
| 10 | 2009 | 63 | |
| 11 | 2015 | 63 | |
| 12 | 2010 | 61 | |
| 13 | 2012 | 60 | |
| 14 | 2011 | 59 | |
| 15 | 2022 | 57 | |
| 16 | 2010 | 50 | |
| 17 | 2018 | 50 | |
| 18 | 2012 | 50 | |
| 19 | 2016 | 46 | |
| 20 | 2010 | 46 |
About Robert Wolff
Robert Wolff is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Economics and Econometrics and Statistics, Probability and Uncertainty, having authored 96 papers that have together received 6.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Brain Metastases and Treatment (9 papers), Meta-analysis and systematic reviews (7 papers), Lung Cancer Treatments and Mutations (5 papers), Glioma Diagnosis and Treatment (4 papers), Pain Mechanisms and Treatments (3 papers) and Intracerebral and Subarachnoid Hemorrhage Research (3 papers). The work is most often cited by research in Health Informatics (180 citations), Pharmacology (1.4k citations), Hepatology (333 citations), Toxicology (128 citations) and Statistics, Probability and Uncertainty (167 citations). Robert Wolff has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Jos Kleijnen, Penny Whiting, Karel G.M. Moons, Richard D Riley, Johannes B. Reitsma, Gary S. Collins, Kate Misso, Steven Duffy, Adrían V. Hernández and Shona Lang. Their work appears in journals such as Cochrane Database of Systematic Reviews, PharmacoEconomics, PLoS ONE, Acta Neurochirurgica and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.